UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 537

Sortiert nach

Alterations in serotonin metabolism in the irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (2), p.272-282

2016

Volltextzugriff (PDF)

Review article: the role of butyrate on colonic function

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (2), p.104-119

2008

Volltextzugriff (PDF)

High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (9), p.1004-1013

2016

Volltextzugriff (PDF)

Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders

Alimentary pharmacology & therapeutics, 2014-08, Vol.40 (3), p.288-297

2014

Volltextzugriff (PDF)

Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors

Alimentary pharmacology & therapeutics, 2023-11, Vol.58 (10), p.1041-1051

2023

Volltextzugriff (PDF)

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study

Neurogastroenterology and motility, 2018-02, Vol.30 (2), p.n/a

2018

Volltextzugriff (PDF)

Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (10), p.1172-1187

2013

Volltextzugriff (PDF)

Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2014-08, Vol.40 (4), p.392-402

2014

Volltextzugriff (PDF)

Habitual diet and diet quality in Irritable Bowel Syndrome: A case‐control study

Neurogastroenterology and motility, 2017-12, Vol.29 (12), p.n/a

2017

Volltextzugriff (PDF)

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (1), p.45-56

2016

Volltextzugriff (PDF)

Review article: probiotics in gastrointestinal and liver diseases

Alimentary pharmacology & therapeutics, 2007-12, Vol.26 (s2), p.133-148

2007

Volltextzugriff (PDF)

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Clinical gastroenterology and hepatology, 2018-10, Vol.16 (10), p.1673-1676

2018

Volltextzugriff (PDF)

Crashing NASH in Patients Listed for Bariatric Surgery

Obesity surgery, 2019-03, Vol.29 (3), p.1012-1014

2019

Volltextzugriff (PDF)

The effects of butyrate enemas on visceral perception in healthy volunteers

Neurogastroenterology and motility, 2009-09, Vol.21 (9), p.952-e76

2009

Volltextzugriff (PDF)

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Gut microbes, 2021-01, Vol.13 (1), p.1943288-1943288

2021

Volltextzugriff (PDF)

Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome

Neurogastroenterology and motility, 2017-12, Vol.29 (12), p.n/a

2017

Volltextzugriff (PDF)

The Experience Sampling Method ‐ a new digital tool for momentary symptom assessment in IBS: an exploratory study

Neurogastroenterology and motility, 2015-09, Vol.27 (9), p.1295-1302

2015

Volltextzugriff (PDF)

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?

European journal of pain, 2013-10, Vol.17 (9), p.1299-1306

2013

Volltextzugriff (PDF)

Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff

Neurogastroenterology and motility, 2012-08, Vol.24 (8), p.729-e346

2012

Volltextzugriff (PDF)

The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1244-1254

2017

Volltextzugriff (PDF)

Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism – a preliminary study

Neurogastroenterology and motility, 2015-08, Vol.27 (8), p.1127-1137

2015

Volltextzugriff (PDF)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

BMJ open, 2021-05, Vol.11 (5), p.e042885-e042885

2021

Volltextzugriff (PDF)

Participation in colorectal cancer screening trials after first-time invitation: a systematic review

Endoscopy, 2011-12, Vol.43 (12), p.1059

2011

Volltextzugriff (PDF)

Editorial: serotonin and irritable bowel syndrome – reconciling pharmacological effects with basic biology; authors' reply

Alimentary pharmacology & therapeutics, 2016-03, Vol.43 (5), p.646-647

2016

Volltextzugriff (PDF)

1 – 25 von 537

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(492)
Mit Volltextzugriff
(491)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alterations in serotonin metabolism in the irritable bowel syndrome

Review article: the role of butyrate on colonic function

High risk of drug‐induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors

Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders

Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study

Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease

Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome

Habitual diet and diet quality in Irritable Bowel Syndrome: A case‐control study

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach

Review article: probiotics in gastrointestinal and liver diseases

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Crashing NASH in Patients Listed for Bariatric Surgery

Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome

The effects of butyrate enemas on visceral perception in healthy volunteers

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome

The Experience Sampling Method ‐ a new digital tool for momentary symptom assessment in IBS: an exploratory study

Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: A role in pain symptom generation?

Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff

The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis

Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism – a preliminary study

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

Participation in colorectal cancer screening trials after first-time invitation: a systematic review

Editorial: serotonin and irritable bowel syndrome – reconciling pharmacological effects with basic biology; authors' reply

Suchergebnisse filtern